Search results
Results from the WOW.Com Content Network
Asymptomatic elevation of serum liver enzyme concentrations occurs in 10% to 20% of people taking INH, and liver enzyme concentrations usually return to normal even when treatment is continued. [27] Isoniazid has a boxed warning for severe and sometimes fatal hepatitis, which is age-dependent at a rate of 0.3% in people 21 to 35 years old and ...
The main result was a relative risk (RR) of 0.40 (95% confidence interval (CI) 0.31 to 0.52) for development of active tuberculosis over two years or longer for patients treated with INH, with no significant difference between treatment courses of six or 12 months (RR 0.44, 95% CI 0.27 to 0.73 for six months, and 0.38, 95% CI 0.28 to 0.50 for ...
Side effects are those of the underlying medications. [1] More common side effects include poor coordination, numbness, and liver problems. [2] Liver problems may be severe and are more likely in people over the age of 50. [2] Use is not recommended in children. [1] It is unclear if use in pregnancy is safe for the baby. [2]
A year later, 22 of them were tested, and their cognitive scores were like 19-year-olds. “They did not enjoy parts of it,” she says of the intervention, especially at first, and it was ...
On 28 December 2012, the U.S. Food and Drug Administration (FDA) approved bedaquiline (marketed as Sirturo by Johnson & Johnson) to treat multidrug-resistant tuberculosis, the first new treatment in 40 years. Sirturo is to be used in a combination therapy for patients who have failed standard treatment and have no other options.
If you or someone you know is struggling with alcohol dependence, misuse or addiction, contact the Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline at 800-662 ...
Rifapentine, sold under the brand name Priftin, is an antibiotic used in the treatment of tuberculosis. [2] In active tuberculosis it is used together with other antituberculosis medications. [2] In latent tuberculosis it is typically used with isoniazid. [2] It is taken by mouth. [2]
For all adults in the second quarter of 2024, at least 1 in 10 people (13%) reported using mental health counseling in the past year, up from a little over 12% in 2022.